infecti
diseas
treatment
pharmaceut
vaccin
face
three
univers
challeng
difficulti
target
treatment
highrisk
superspread
popul
drive
great
major
diseas
spread
behavior
barrier
host
popul
poor
complianc
risk
disinhibit
evolut
pathogen
resist
describ
propos
intervent
would
overcom
challeng
capit
upon
therapeut
interf
particl
tip
engin
replic
condit
presenc
pathogen
spread
individu
analog
transmiss
immun
occur
liveattenu
vaccin
without
potenti
revers
virul
build
analys
hiv
field
data
subsaharan
africa
construct
multiscal
model
begin
singlecel
level
predict
effect
tip
individu
patient
viral
load
ultim
populationlevel
diseas
preval
result
show
tip
engin
properti
base
recent
hiv
genetherapi
trial
could
stabli
lower
hivaid
preval
within
year
could
complement
current
therapi
contrast
optimist
antiretrovir
therapi
vaccin
campaign
alon
could
lower
hivaid
preval
year
tip
efficaci
aris
exploit
risk
factor
pathogen
allow
autonom
penetr
superspread
popul
maintain
efficaci
despit
behavior
disinhibit
limit
viral
resist
demonstr
hiv
tip
concept
could
appli
broadli
mani
viral
infecti
diseas
would
repres
new
paradigm
diseas
control
away
pathogen
erad
toward
robust
diseas
suppress
core
group
superspread
epidemiologist
long
recogn
immens
potenti
target
highrisk
group
effici
control
infecti
diseas
group
often
describ
classic
rule
individu
drive
diseas
transmiss
thu
domin
overal
pattern
diseas
preval
sexual
transmit
bloodborn
infect
hepat
c
syphili
term
hiv
superspread
driven
highrisk
sexual
needleshar
behavior
mani
pathogen
span
broad
rang
transmiss
mode
life
histori
superspread
play
import
role
transmiss
dynam
underli
mechan
remain
poorli
understood
target
superspread
subpopul
therapeut
prevent
measur
would
tremend
increas
efficaci
diseas
control
failur
target
highrisk
group
weaken
effort
achiev
herd
immun
vaccin
sever
limit
abil
reduc
diseas
popul
level
unfortun
identifi
crucial
highrisk
popul
requir
indepth
knowledg
social
sexual
network
underli
diseas
spread
rare
attain
well
knowledg
asyet
unknown
biolog
correl
risk
aggrav
problem
target
superspread
nonhealthseek
behavior
key
popul
inject
drug
user
idu
ii
selfconceal
motiv
social
stigma
crimin
barrier
highrisk
individu
idu
men
sex
men
peopl
extramarit
sexual
partner
commerci
sex
worker
client
result
high
cost
effort
involv
identifi
highrisk
popul
meant
thatdespit
huge
potenti
benefitstarget
diseas
control
measur
highrisk
popul
often
feasibl
practic
propos
fundament
differ
approach
obviat
need
directli
identifi
highrisk
popul
engin
therapeut
version
interf
particl
ie
tip
spread
individu
autonom
target
highrisk
group
result
demonstr
potenti
tip
control
hiv
subsaharan
africa
benchmark
perform
tip
familiar
altern
antiretrovir
therapi
art
known
effect
reduc
hiv
incid
preval
hypothet
protect
vaccin
hiv
demonstr
effect
tip
complementari
art
program
propos
therapi
could
roll
synergist
current
campaign
tip
concept
capit
upon
extend
phenomenon
interf
particl
occur
natur
mani
virus
spread
along
viral
pathogen
demonstr
potenti
therapeut
efficaci
hiv
tip
minim
version
pathogen
engin
lack
virul
replic
structur
gene
wildtyp
pathogen
instead
encod
therapeut
element
target
key
host
viral
process
sinc
tip
genom
significantli
shorter
wildtyp
viru
genom
tip
genom
synthes
faster
rate
result
increas
number
tip
genom
compar
wildtyp
viru
genom
infect
cell
see
text
specif
hiv
propos
tip
lentivir
genetherapi
vector
lack
structur
envelop
gene
requir
selfrepl
retain
hiv
genom
packag
signal
tip
mobil
infect
cell
coopt
wildtyp
hiv
capsid
envelop
geneproduct
parasit
pathogen
resourc
tip
mobil
cell
cell
recent
clinic
trial
mobil
genetherapi
vector
hiv
appear
detriment
patient
health
due
abil
mobil
reproduc
within
host
tip
potenti
decreas
wildtyp
pathogen
level
vivo
mani
order
magnitud
share
packag
element
wildtyp
pathogen
tip
also
potenti
spread
individu
would
spread
via
transmiss
rout
diseasecaus
pathogen
respect
combat
infecti
diseas
use
tip
rais
uniqu
safeti
ethic
concern
bear
similar
use
live
attenu
vaccin
particular
recogn
advantag
oral
polio
vaccin
opv
replic
vivo
shed
therebi
transmit
among
suscept
host
deliv
addit
protect
via
transmiss
immun
popul
scale
howev
crucial
differ
tip
live
attenu
vaccin
tip
replic
uninfect
host
tip
remain
dormant
host
coinfect
wildtyp
pathogen
ii
replic
element
miss
tip
unlik
opv
tip
revert
virul
healthi
individu
test
whether
tip
hiv
could
autonom
target
highrisk
group
effect
reduc
hiv
preval
build
upon
establish
epidemiolog
model
hivaid
transmiss
subsaharan
africa
includ
four
class
sexual
risk
behavior
base
field
data
develop
datadriven
threescal
model
figur
translat
molecularlevel
characterist
tip
predict
patientlevel
hiv
viral
load
ultim
predict
hivaid
incid
preval
popul
scale
singlecel
level
model
consid
dynam
competit
tip
genom
mrna
hiv
genom
mrna
packag
compon
molecularlevel
effect
tip
translat
viral
load
use
establish
vivo
model
hiv
dynam
includ
tip
dynam
measur
relationship
viral
load
transmiss
use
estim
tip
hiv
transmiss
rate
individu
rate
diseas
progress
estim
base
field
data
hiv
viral
load
see
text
art
model
assum
optimist
testandtreat
deploy
infect
highrisk
lowrisk
popul
treat
regimen
stop
hiv
transmiss
testandtreat
model
differ
previou
project
incorpor
two
addit
behavior
factor
describ
real
popul
art
failur
dropout
rate
measur
subsaharan
african
popul
ii
popul
risk
structur
model
predict
smaller
benefit
testandtreat
program
earlier
work
result
consist
previou
art
project
incorpor
risk
structur
vaccin
model
assum
optimist
immun
coverag
coverag
highrisk
lowrisk
popul
consid
vaccin
protect
slightli
higher
report
recent
thai
trial
hypothet
protect
vaccin
lifelong
efficaci
assum
vaccin
ie
hiv
mutat
escap
tip
tip
analyz
intervent
gener
viralload
reduct
vivo
report
recent
hiv
genetherapi
trial
model
predict
effect
vaccin
tip
intervent
hivaid
preval
resourcepoor
subsaharan
set
strikingli
tip
intervent
reduc
diseas
preval
incid
effect
either
widespread
art
protect
vaccin
hivaid
figur
least
effect
tip
analyzedwhich
reduc
hiv
vivo
viral
load
copiesml
lead
reduct
hivaid
preval
year
despit
initi
deploy
individu
tip
gener
decreas
hiv
viralloada
transient
achiev
phasei
clinic
trial
hiv
genetherapi
would
reduc
hivaid
preval
preval
year
figur
comparison
introduc
propos
intervent
infecti
diseas
extend
optim
recogn
benefit
transmiss
immun
occur
liveattenu
vaccin
oral
polio
vaccin
opv
vaccin
chosen
worldwid
polio
erad
campaign
intervent
propos
base
upon
therapeut
interf
particl
tip
engin
replic
presenc
wildtyp
pathogen
act
inhibit
growth
pathogen
therefor
tip
piggyback
pathogen
lead
two
import
differ
liveattenu
vaccin
tip
transmit
individu
alreadi
infect
wildtyp
pathogen
tip
could
revert
virul
individu
alreadi
carri
wildtyp
pathogen
intriguingli
tip
spread
individu
use
transmiss
rout
pathogen
automat
find
way
popul
greatest
risk
infect
thu
circumv
unsolv
problem
identifi
superspread
target
prevent
measur
base
clinicaltri
data
analyz
impact
tip
intervent
would
hivaid
subsaharan
africa
show
tip
could
lower
hivaid
preval
effect
vaccin
drug
alon
fact
would
effect
complement
intervent
protect
vaccin
deploy
entir
popul
includ
uninfect
highrisk
individu
reduc
hivaid
preval
year
protect
vaccin
deploy
entir
popul
includ
virtual
uninfect
highrisk
individu
reduc
hivaid
preval
year
art
treat
new
infect
would
reduc
diseas
preval
level
protect
vaccin
strike
shortterm
impact
tip
intervent
hiv
incid
compar
vaccin
art
also
project
figur
despit
extrem
rapid
rollout
vaccin
art
figur
text
similar
result
obtain
compar
tip
intervent
vaccin
art
term
either
fractionofindividualslivingwithaid
aid
incid
figur
text
thu
tip
construct
use
paramet
recent
report
phasei
trial
given
small
fraction
popul
potenti
swiftli
substanti
reduc
diseas
burden
popul
level
efficaci
robust
tip
intervent
aris
uniqu
defin
abil
tip
transmit
host
analysi
tip
gener
log
decreas
viral
load
transmit
host
show
minim
decreas
populationlevel
diseas
burden
figur
text
agreement
project
impact
acyclovir
treatment
also
gener
log
decreas
hiv
viral
load
accordingli
paid
particular
attent
ensur
result
robust
respect
chang
basic
model
assumpt
transmiss
biolog
robust
paramet
sensit
analysi
see
text
also
consid
two
compet
model
hiv
transmiss
biologyinfect
either
singl
founder
viru
enter
new
host
individu
bottleneck
multipl
virus
enter
replic
local
winnow
competit
within
host
provid
argument
treatment
tip
transmiss
consist
either
transmiss
mode
tip
could
transmit
effici
either
case
see
text
section
bold
figur
repres
transmiss
rate
size
figur
repres
size
sexual
activ
class
smallest
boldest
figur
repres
superspread
least
number
highest
transmiss
rate
largest
lightest
figur
repres
individu
lowest
transmiss
rate
greatest
number
infect
tip
alon
blue
convert
suscept
individu
latent
carrier
integr
tip
genom
infect
hiv
convert
suscept
individu
individu
progress
diseas
yr
dual
infect
gener
individu
progress
diseas
slowli
diseas
progress
transmiss
rate
proport
vivo
viral
load
entitl
consider
tip
transmiss
uninfect
host
complet
sure
model
result
robust
chang
assumpt
tip
transmiss
repeat
simul
worstcas
assumpt
tip
complet
unabl
transmit
absenc
hiv
found
result
qualit
unchang
figur
see
text
section
sensit
model
remov
independ
transmiss
tip
ie
remov
individu
somewhat
surpris
result
aris
tip
autonom
target
highestrisk
group
highli
like
alreadi
infect
hiv
due
highrisk
statu
thu
major
tip
infect
flow
occur
alreadi
infect
individu
summari
physiolog
basi
support
tip
could
transmit
effici
hivuninfect
person
efficaci
tip
intervent
larg
independ
assumpt
ie
tip
need
convert
suscept
individu
tip
carrier
populationlevel
efficaci
retain
result
intend
argu
art
campaign
abandon
vaccin
trial
halt
contrari
show
tip
abil
target
highrisk
group
allow
tip
complement
art
vaccin
campaign
significantli
enhanc
populationlevel
efficaci
approach
current
prevent
treatment
approach
also
face
challeng
poor
complianc
behavior
disinhibit
wherein
success
diseas
control
lead
reduc
sens
person
risk
diseas
result
increas
risk
behavior
disinhibit
signific
concern
current
hiv
prevent
control
potenti
gener
pervers
outcom
success
therapeut
may
actual
increas
hiv
incid
transmiss
singledos
administr
tip
effect
circumv
problem
unlik
current
pharmaceut
approach
ie
art
vaccin
inde
public
health
benefit
tip
uniqu
robust
disinhibit
sinc
intervent
spread
effect
contact
rate
increas
figur
contrast
degre
disinhibit
presenc
art
protect
initi
deploy
individu
tip
intervent
compar
protect
vaccin
light
grey
protect
vaccin
dark
grey
art
black
vaccin
scenario
base
protect
level
report
recent
clinic
trial
unaid
target
protect
goal
protect
vaccin
assum
lifelong
efficaci
optimist
level
coverag
coverag
risk
group
respect
art
scenario
assum
treat
infect
use
univers
testandtreat
approach
art
efficaci
halt
hiv
transmiss
vaccin
could
unfortun
effect
increas
hivaid
preval
could
increas
number
death
due
aid
figur
highlight
previou
analys
intervent
hiv
like
administ
context
exist
standard
care
art
sinc
art
halt
hiv
transmiss
art
would
also
halt
tip
transmiss
individu
lead
potenti
tip
intervent
could
sever
hamper
howev
tip
abil
concentr
highestrisk
group
see
next
paragraph
art
best
target
coverag
fraction
eg
would
allow
tip
intervent
maintain
efficaci
reduc
hivaid
diseas
preval
reduc
aid
death
effect
art
alon
even
optimist
coverag
scenario
art
campaign
figur
thu
art
would
interfer
tip
intervent
popul
scale
tip
could
use
power
complement
art
pharmaceut
treatment
gener
increas
efficaci
tip
rel
vaccin
due
tip
transmiss
along
transmiss
rout
pathogen
consequ
tip
transmit
specif
risk
group
proport
group
risk
behavior
lead
focus
target
tip
heterogen
popul
result
tip
concentr
highestrisk
popul
figur
contrast
reach
highrisk
class
art
depend
upon
activ
sustain
target
rare
highrisk
individu
partiallyprotect
vaccin
tend
concentr
lowest
risk
class
higherrisk
individu
still
becom
hivinfect
given
partial
protect
vaccin
lack
abil
dynam
redistribut
risk
class
figur
vaccin
drug
treatment
strategi
also
face
challeng
mutat
strong
select
pressur
pathogen
escap
success
control
hiv
rapid
mutat
lead
resist
antiretrovir
therapi
pose
signific
challeng
vaccin
develop
howev
unlik
convent
therapi
tip
replic
speed
mutat
rate
pathogen
set
evolutionari
arm
race
tip
pathogen
examin
hiv
might
respond
arm
race
result
tip
intervent
consid
multiscal
dynam
across
rang
paramet
valu
molecularlevel
properti
use
design
tip
specif
consid
interplay
hiv
tip
level
function
strength
tipencod
inhibit
hiv
engin
tip
genom
abund
within
dualli
infect
cell
hiv
tip
design
encod
inher
evolutionari
tradeoff
gener
conflict
select
pressur
differ
scale
figur
one
hand
inhibit
hiv
replic
tipencod
therapi
gene
inevit
limit
tip
productionsinc
tipencod
antivir
inhibit
hiv
compromis
tip
abil
mobil
howev
due
diploid
natur
retrovir
genom
high
concentr
tip
genom
mrna
alon
inhibit
hiv
product
wast
major
hiv
genom
virion
contain
one
hiv
rna
one
tip
rna
heterozygousdiploid
virion
viabl
thu
lowest
tipmedi
inhibit
gener
highest
product
tip
infect
cell
figur
increas
number
tip
virion
compet
effect
hiv
target
cell
gener
greater
reduct
hiv
viralload
patientlevel
figur
lowest
hivaid
preval
popul
figur
result
suggest
nonintuit
design
criterion
tip
hiv
tip
lack
inhibitori
factor
hiv
effect
reduc
hiv
level
individu
patient
popul
level
similarli
cellularscal
select
pressur
hiv
escap
tipencod
inhibit
would
point
direct
toward
zero
tip
inhibitori
effect
would
lead
increas
tip
product
figur
counterintuit
hiv
escap
tipmedi
inhibit
molecular
scale
within
cell
would
reduc
hiv
viral
load
hiv
popul
preval
lower
level
figur
tip
approach
carri
uniqu
safeti
concern
ethic
concern
associ
introduc
intervent
transmit
evolv
even
tip
limit
fashion
within
popul
importantli
clear
ethic
preced
transmiss
therapi
exist
use
liveattenu
vaccin
regard
safeti
one
major
concern
tip
may
recombin
ie
acquir
element
upregul
pathogen
product
turn
upregul
product
cell
explor
concern
examin
hiv
viral
load
popul
preval
regim
tip
encod
hiv
inhibit
regim
tip
encod
potenti
upregul
hiv
gene
express
within
singl
cell
figur
expect
singlecel
level
upregul
hiv
gener
increas
hiv
tip
product
howev
individu
patient
level
upregul
hiv
lead
increas
tip
viral
load
figur
inset
actual
gener
even
lower
hiv
viral
load
figur
hiv
popul
preval
figur
interestingli
popul
level
optim
valu
tipencod
inhibit
yield
maximum
tip
preval
figur
inset
thu
tip
appear
subject
compet
select
pressur
multipl
scale
may
limit
potenti
evolutionari
breakdown
tip
therapi
echo
recent
propos
antivir
resist
viral
escap
evolutionproof
malaria
insecticid
detail
experiment
theoret
studi
requir
predict
ultim
direct
tip
evolut
compet
select
pressur
may
effect
constrain
tip
phenotyp
rang
assur
low
hiv
viral
load
low
hiv
diseas
preval
tip
evolut
like
domin
mutat
process
sinc
recombin
tip
wildtyp
hiv
appear
sever
limit
fundament
sequencehomolog
constraint
retrovir
recombin
render
recombin
fulllength
kb
hiv
genom
shorter
lentivir
genom
eg
tip
noncompet
integr
molecular
argument
recombin
hiv
tip
also
support
data
murin
model
recent
human
clinic
trial
data
neither
detect
recombin
wildtyp
shorter
lentivir
therapi
vector
fulli
address
safeti
obvious
need
cautiou
trial
vitro
vivo
tip
intervent
could
ever
consid
implement
importantli
tip
hiv
would
specif
target
requir
stem
cell
sinc
tip
would
target
cell
hiv
primarili
lymphocyt
thu
oncogen
concern
result
insert
mutagenesi
minim
argument
support
recent
phasei
lentivir
genetherapi
clinic
trial
hiv
previou
gene
therapi
peripher
blood
lymphocyt
patient
follow
sinc
neither
detect
insert
mutagenesi
oncogen
transform
patient
model
analysi
rel
simpl
represent
complex
system
necessarili
make
certain
assumpt
importantli
tip
robust
efficaci
stem
uniqu
defin
abil
tip
transmit
host
gener
result
present
tip
qualit
robust
chang
paramet
valu
basic
model
assumpt
transmiss
biolog
see
text
tip
efficaci
also
appear
qualit
robust
decreas
transmiss
effici
result
widespread
art
coverag
figur
reparameter
transmiss
function
see
text
nevertheless
analysi
intend
first
step
toward
motiv
research
transmiss
therapi
rather
proof
efficaci
molecular
epidemiolog
ethic
base
use
tip
intervent
pathogen
requir
extens
studi
result
show
tip
may
offer
uniqu
strategi
target
highrisk
hardtoreach
popul
overcom
behavior
barrier
circumv
mutat
escap
achiev
indefinit
diseas
suppress
hiv
possibl
pathogen
resourcelimit
set
ad
benefit
intervent
resourcelimit
set
tip
may
potenti
administ
therapi
requir
singl
dose
therebi
allow
abil
tip
intervent
penetr
riskclass
report
fraction
riskclass
expos
intervent
time
despit
introduct
far
individu
lowest
risk
class
due
assumpt
uniform
initi
coverag
tip
mobil
highest
risk
superspread
class
solid
dash
line
repres
simul
presenc
behavior
disinhibit
respect
b
abil
protect
vaccin
administ
popul
penetr
riskclass
report
fraction
riskclass
expos
vaccin
time
solid
dash
line
repres
simul
presenc
behavior
disinhibit
respect
contrast
tip
protect
vaccin
directli
target
highest
risk
class
quickli
deplet
highest
riskclass
given
partial
protect
highrisk
individu
still
becom
infect
rel
rapidli
increas
treatment
access
minim
treatment
complianc
issu
result
show
deploy
tip
therapi
even
individu
alreadi
infect
reduc
preval
diseas
low
level
due
rapid
sustain
transmiss
dynam
highrisk
group
impact
tip
intervent
robust
even
tip
quickli
clear
tip
carrier
individu
rapidli
revert
back
suscept
see
text
abil
enter
provir
latenc
dormant
tip
could
complementari
art
individu
scale
reactiv
art
failur
act
reduc
viral
load
recent
model
argu
widespread
art
campaign
alon
could
halt
hivaid
pandem
remain
signific
controversi
whether
art
succeed
reduc
overal
hiv
transmiss
especi
presenc
highrisk
group
exhibit
treatment
noncompli
signific
challeng
achiev
widespread
art
coverag
resourcelimit
set
includ
slowerthanhop
rollout
persist
logist
problem
link
insuffici
health
system
weak
infrastructur
need
ongo
highlevel
donor
fund
social
stigma
prevent
peopl
get
test
henc
start
treatment
factor
like
produc
longterm
heterogen
coverag
impoverish
disadvantag
group
receiv
least
access
art
base
challeng
prudent
consid
altern
complementari
approach
multiscal
analysi
tip
built
upon
previou
datadriven
model
compos
three
constitu
ordinari
differenti
equat
model
describ
dynam
differ
hierarch
scale
among
popul
host
individu
popul
level
ii
within
host
individu
individu
patient
iii
within
infect
host
cell
intracellular
multiscal
model
specifi
mechanist
link
scale
next
scale
organiz
complex
intracellular
r
vivo
r
popul
level
populationlevel
tip
model
simplifi
version
riskstructur
model
construct
unaid
fielddata
collect
antenat
clinic
malawi
includ
riskstructur
formul
four
distinct
sexualact
class
sac
refer
baggaley
model
individu
classifi
suscept
hiv
infect
suscept
hiv
infect
tip
dualli
infect
hiv
tip
aid
patient
wildtyp
viru
w
dualli
infect
aid
patient
individu
diseasest
divid
sac
accord
field
data
indic
subscript
except
individu
w
class
assum
sexual
contact
rate
correspond
lowest
risk
group
sac
owe
poor
health
model
equat
follow
paramet
definit
valu
correspond
refer
shown
tabl
text
transmiss
probabl
per
partnership
denot
b
x
repres
diseas
state
sourc
infect
x
repres
viral
strain
wildtyp
hiv
denot
x
w
vaccin
model
perpartnership
transmiss
probabl
b
w
describ
transmiss
wildtyp
hiv
individu
diseas
state
set
agre
weight
averag
baggaley
model
b
w
perpartnership
probabl
wildtyp
hiv
infect
origin
aid
patient
set
follow
baggaley
model
consider
altern
parameter
viral
load
transmiss
curv
qualit
affect
result
see
text
paramet
b
w
c
static
paramet
repres
transmiss
probabl
durat
asymptomat
phase
individu
infect
wildtyp
viru
contrast
describ
quantiti
depend
specif
design
tip
transmiss
probabl
ii
durat
asymptomat
period
function
use
place
paramet
function
calcul
base
measur
correl
transmiss
diseas
progress
viral
load
viral
load
predict
vivo
tip
model
see
text
exampl
transmiss
probabl
presenc
tip
durat
asymptomat
phase
duallyinfect
individu
tip
popul
model
repres
function
steadyst
viral
load
ie
viral
set
point
predict
vivo
model
see
tabl
text
descript
transmissionprob
function
function
c
v
use
comput
durat
asymptomat
phase
duallyinfect
individu
also
calcul
text
contact
individu
tip
popul
model
weight
statist
independ
transmiss
probabl
b
calcul
steadyst
hiv
tip
viral
load
vivo
model
see
text
section
calcul
transmissionr
function
six
distinct
transit
infect
class
tip
popul
model
see
tabl
text
detail
briefli
contact
two
individu
repres
contact
function
consid
asymmetr
mix
individu
among
four
sac
contact
function
describ
individu
diseas
state
x
sac
becom
infect
individu
diseas
state
subscript
j
denot
sac
j
c
j
averag
number
sexual
partner
per
year
sac
j
n
j
sum
sexual
activ
individu
sac
j
contact
function
e
degre
assort
mix
correspond
entir
assort
mix
correspond
entir
random
mix
first
term
insid
bracket
contact
function
describ
assort
mix
infect
individu
encount
proport
preval
sac
second
term
describ
random
contact
infect
individu
encount
proport
contribut
sexual
contact
made
entir
popul
set
mix
paramet
e
equal
estim
simul
tip
popul
model
conduct
follow
baggaley
model
allow
reach
steadyst
tip
introduc
individu
without
target
highrisk
class
similar
benefit
obtain
use
much
restrict
initi
condit
eg
util
tip
therapi
target
tip
w
individu
least
activ
sacssac
sac
similar
result
figur
behavior
disinhibit
simul
increas
contact
rate
c
sac
number
aid
death
avert
vaccin
campaign
defin
aid
death
avert
aid
death
year
epidem
without
treatment
aid
death
year
epidem
follow
year
treatment
vaccin
art
model
use
risk
structur
present
text
complet
list
model
paramet
state
variabl
present
tabl
text
numer
simul
perform
mathematica
text
full
descript
multiscal
model
use
predict
effect
tip
intervent
infect
dynam
among
popul
host
individu
within
host
individu
within
host
cell
report
contain
detail
descript
model
tabl
paramet
state
variabl
support
figur
analysi
sensit
tip
model
chang
paramet
analysi
sensit
tip
model
chang
structur
chang
basic
transmiss
biolog
pdf
